Table 2.
Baseline characteristics.
| Patient | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 |
|---|---|---|---|---|---|---|---|---|
| Age in years | 53 | 45 | 45 | 42 | 71 | 47 | 66 | 55 |
| Sex | M | F | M | F | M | F | M | M |
| Comorbidity | none | none | none | none | IHD | none | none | none |
| Primary site | Supra glottis | PFS | Post cricoid | PFS | Supra glottis | PFS | Supra glottis | Supra glottis |
| T stage | 3 | 4a | 3 | 4a | 3 | 3 | 3 | 4 |
| Minor thyroid cartilage invasion | No | Yes | No | Yes | No | No | No | yes |
| N stage | 0 | 0 | 3 | 1 | 2c | 2c | 0 | 2a |
| Stage | III | IVa | IVb | IVa | IVa | IVa | III | IVa |
| BMI (Kg/m2) | 22 | 15 | 27 | 18 | 24 | 18 | 19 | 22 |
| ECOG performance status | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Haemoglobin (g/dL) | 10 | 9.6 | 12 | 11.5 | 13 | 11 | 12 | 13 |
| Albumin (mg/dL) | 4 | 3 | 4 | 4.2 | 3.7 | 3.8 | 3.6 | 3.7 |
IHD: ischemic heart disease, PFS: pyriform sinus, M: male, F: female.